Review of the use of radiomics to assess the risk of recurrence in early-stage non-small cell lung cancer
Authors:
Open Access
- 1 July 2023
- journal article
- review article
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 12 (7) , 1575-1589
Abstract
Background and Objective: Radiomics is an emerging field of advanced image analysis that has shown promise as a non-invasive, companion diagnostic in predicting clinical outcomes and response assessments in solid tumors. Radiomics aims to extract high-content information from medical images not visible to the naked eye, especially in early-stage non-small cell lung cancer (NSCLC) patients. Although these patients are being identified by early detection programs, it remains unclear which patients would benefit from adjuvant treatment versus active surveillance. Having a radiomic signature(s) that could predict early recurrence would be beneficial. In this review, an overview of the basic radiomic approaches used to evaluate solid tumors on radiologic scans, including NSCLC is provided followed by a review of relevant literature that supports the use of radiomics to help predict tumor recurrence in early-stage NSCLC patients. Methods: A review of the radiomic literature from 1985 to present focusing on the prediction of disease recurrence in early-stage NSCLC was conducted. PubMed database was searched using key terms for radiomics and NSCLC. A total of 41 articles were identified and 13 studies were considered suitable for inclusion based upon study population, patient number (n>50), use of well described radiomic methodologies, suitable model building features, and well-defined testing/training and validation where feasible. Key Content and Findings: Examples of using radiomics in early-stage NSCLC patients will be presented, where disease free survival is a primary consideration. A summary of the findings demonstrates the importance of both the intratumor and peritumoral radiomic signals as a marker of outcomes. Conclusions: The value of radiomic information for predicting disease recurrence in early-stage NSCLC patients is accumulating. However, overcoming several challenges along with the lack of prospective trials, has inhibited it use as a clinical decision-making support tool in early-stage NSCLC.Keywords
This publication has 39 references indexed in Scilit:
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2014
- Robust Radiomics Feature Quantification Using Semiautomatic Volumetric SegmentationPLOS ONE, 2014
- Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is PrognosticPLOS ONE, 2014
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachNature Communications, 2014
- Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcomeThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Volumetric CT-based segmentation of NSCLC using 3D-SlicerScientific Reports, 2013
- A Collaborative Enterprise for Multi-Stakeholder Participation in the Advancement of Quantitative ImagingRadiology, 2011
- Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parametersActa Oncologica, 2010
- Decoding global gene expression programs in liver cancer by noninvasive imagingNature Biotechnology, 2007